香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對 其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內 容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Global Mastermind Holdings Limited 環球大通集團有限公司 * （於開曼群島註冊成立之有限公司） （股份代號：8063） 有關復牌狀況之季度更新資料 本公告乃Global Mastermind Holdings Limited環球大通集團有限公司*（「本公司」，連同 其附屬公司，「本集團」）根據香港聯合交易所有限公司（「聯交所」）GEM證券上市規則 （「 GEM上市規則」）第17.10條及第17.26A條以及香港法例第571章證券及期貨條例第 XIVA部項下之內幕消息條文（定義見GEM上市規則）刊發。 茲提述本公司日期為二零二四年十月七日、二零二四年十月八日、二零二四年十月十七 日、二零二五年二月七日、二零二五年二月十日、二零二五年二月十八日、二零二五年 二月十九日、二零二五年二月二十八日、二零二五年四月一日、二零二五年五月十六 日、二零二五年八月十二日、二零二五年八月二十 ...

Group 1 - Metsera, a weight loss drug manufacturer, surged 58.9% after announcing its acquisition by Pfizer for $4.9 billion in cash [1] - Pfizer's stock increased by 1.0% following the acquisition announcement [1] - Compass, a brokerage giant, plans to acquire competitor Anywhere in an all-stock deal valued at $1.6 billion, leading to a 55.5% rise in Anywhere's stock [1] Group 2 - Compass's stock fell by 7.9% in response to the acquisition news [1] - Sarepta Therapeutics rose by 6.8% after BMO upgraded its stock rating to "outperform," predicting the stock price could more than double [1] - WeRide, a company in the autonomous driving sector, increased by 2.3% as it announced the launch of its autonomous taxi service in Singapore [1]